Challenges to advancing the evidence base for nephrology: the time is right for collaboration.

about

Challenges to advancing the evidence base for nephrology: the time is right for collaboration.

Item

http://www.wikidata.org/entity/Q54580362

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Challenges to advancing the ev ...... me is right for collaboration.

@en

Challenges to advancing the ev ...... me is right for collaboration.

@nl

type

Item

label

Challenges to advancing the ev ...... me is right for collaboration.

@en

Challenges to advancing the ev ...... me is right for collaboration.

@nl

prefLabel

Challenges to advancing the ev ...... me is right for collaboration.

@en

Challenges to advancing the ev ...... me is right for collaboration.

@nl

P1476

Challenges to advancing the ev ...... me is right for collaboration.

@en

P2093

Donah Zachariah

http://www.w3.org/2001/XMLSchema#string

Kathryn Watson

http://www.w3.org/2001/XMLSchema#string

Paul R Kalra

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

Chronic kidney disease-induced cardiac fibrosis is ameliorated by reducing circulating levels of a non-dialysable uremic toxin, indoxyl sulfate.

The prospective pioglitazone clinical trial in macrovascular events (PROactive): can pioglitazone reduce cardiovascular events in diabetes? Study design and baseline characteristics of 5238 patients.

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.

Clinical epidemiology of cardiovascular disease in chronic kidney disease.

Severe renal impairment and stroke prevention in atrial fibrillation: implications for thromboprophylaxis and bleeding risk.

Clinical utility of biomarkers in chronic kidney disease and chronic heart failure.

Prognostic significance of renal function in elderly patients with isolated systolic hypertension: results from the Syst-Eur trial.

Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease

P304

191-193

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1111/J.1755-6686.2013.12044.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24245970

http://www.w3.org/2001/XMLSchema#string

P921

collaboration